NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

about

Utilizing Animal Models of Infantile Spasms.

P2860

Q55416149-274F3DDE-0318-4032-877E-7A367AD5AA3C

P2860

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

Item

http://www.wikidata.org/entity/Q46098319

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@en

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@nl

type

Item

label

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@en

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@nl

prefLabel

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@en

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@nl

P1476

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

@en

P2093

Amanda J Roberts

http://www.w3.org/2001/XMLSchema#string

Daniel R Holohan

http://www.w3.org/2001/XMLSchema#string

Huaxi Xu

http://www.w3.org/2001/XMLSchema#string

James Parker

http://www.w3.org/2001/XMLSchema#string

Kevin Lopez

http://www.w3.org/2001/XMLSchema#string

Li Yan

http://www.w3.org/2001/XMLSchema#string

Mohd Waseem Akhtar

http://www.w3.org/2001/XMLSchema#string

Neha Bansal

http://www.w3.org/2001/XMLSchema#string

Nobuki Nakanishi

http://www.w3.org/2001/XMLSchema#string

Rajesh Ambasudhan

http://www.w3.org/2001/XMLSchema#string

P2860

A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation

MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex

Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses

Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo

MeCP2, a key contributor to neurological disease, activates and represses transcription

Identifying autism loci and genes by tracing recent shared ancestry

Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date

Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability

Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

P2888

s41467-017-01563-8

P304

1488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-017-01563-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alejandro Amador-Arjona

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092599538

http://www.w3.org/2001/XMLSchema#string

P698

29133852

http://www.w3.org/2001/XMLSchema#string

P921

autism

haploinsufficiency

P932

5684358

http://www.w3.org/2001/XMLSchema#string

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

about

P2860

P2860

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932